Stabilized biodegradable neurotoxin implants

Details for Australian Patent Application No. 2005290334 (hide)

Owner Allergan, Inc.

Inventors Olejnik, Orest; Hughes, Patrick

Agent Davies Collison Cave

Pub. Number AU-B-2005290334

PCT Pub. Number WO2006/036202

Priority 10/826,441 15.04.04 US

Filing date 11 April 2005

Wipo publication date 6 April 2006

Acceptance publication date 25 August 2011

International Classifications

A61L 31/06 (2006.01) Materials for other surgical articles

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 39/08 (2006.01) Medicinal preparations containing antigens or antibodies - Clostridium, e.g. Clostridium tetani

A61L 31/16 (2006.01) Materials for other surgical articles

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2006/036202 Priority application(s): WO2006/036202

25 August 2011 Application Accepted

  Published as AU-B-2005290334

12 April 2012 Corrigenda

  Applications Accepted - Name Index Under the name Allergan, Inc., Application No. 2005290334, under INID (22) correct the filing date to 08.04.05

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005290336-Method of treating an inflammatory disease by double stranded ribonucleic acid

2005290322-Bouquet enhancing wineglass